NEUROGENIC BLADDER SYNDROME IN ELDERLY WOMEN: DIAGNOSTIC CHALLENGES AND MODERN THERAPEUTIC STRATEGIES

Background: Neurogenic bladder syndrome (NBS) in elderly women is a complex clinical entity resulting from the disruption of neural pathways governing lower urinary tract function. In the aging female population, NBS is frequently exacerbated by comorbidities such as stroke, Parkinson’s disease, and post-menopausal changes. Objectives: This study aims to evaluate current diagnostic protocols and analyze the efficacy of modern pharmacological and minimally invasive treatments available in 2026. Methods: A systematic review of literature from 2016 to 2026 was conducted using PubMed, Cochrane Library, and European Association of Urology (EAU) guidelines. Results: Modern diagnostics, including 3D-urodynamics and neuro-imaging, allow for precise sub-typing of NBS. Emerging therapies, such as sacral neuromodulation (SNM) and targeted botulinum toxin A (BoNT-A) injections, have shown superior results compared to traditional anticholinergic therapy. Conclusion: Management of NBS in elderly women requires a multidisciplinary approach, prioritizing minimally invasive interventions to improve quality of life and prevent upper urinary tract damage.